Suman Mondal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suman Mondal has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Samuel Achilefu
University of Texas Southwestern Medical Center
15 shared publications Nan Zhu
University of Arizona, College of Optical Science, 1630 E. University Boulevard, Tucson, Arizona 85721, United States
9 shared publicationsShengkui Gao
Washington University, Department of Computer Science and Engineering, One Bookings Drive, St. Louis, Missouri 63110, United States
9 shared publicationsGail P. Sudlow
Department of Radiology, Washington University, St. Louis, USA
6 shared publicationsViktor Gruev
Department of Computer Science and Engineering, Washington University, St. Louis, MO, USA
6 shared publicationsRongguang Liang
College of Optical Sciences, The University of Arizona, Tuscon, AZ, USA
5 shared publications
Latest Publications
- 6 October 2022
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 13 (11) , 5628-5642
Quantitative tumor depth determination using dual wavelength excitation fluorescence
Quantifying solid tumor margins with fluorescence-guided surgery approaches is a challenge, particularly when using near infrared (NIR) wavelengths due to increased penetration depths. An NIR dual wavelength excitation fluorescence (DWEF) approach was developed that capitalizes on the wavelength-dependent attenuation of light in tissue to determine fluorophore depth. A portable dual wavelength excitation fluorescence imaging system was built and tested in parallel with an NIR tumor-targeting fluorophore in tissue mimicking phantoms, chicken tissue, and in vivo mouse models of breast cancer. The system showed high accuracy in all experiments. The low cost and simplicity of this approach make it ideal for clinical use.
- 6 October 2022
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 13 (11) , 5628-5642
Quantitative tumor depth determination using dual wavelength excitation fluorescence
Quantifying solid tumor margins with fluorescence-guided surgery approaches is a challenge, particularly when using near infrared (NIR) wavelengths due to increased penetration depths. An NIR dual wavelength excitation fluorescence (DWEF) approach was developed that capitalizes on the wavelength-dependent attenuation of light in tissue to determine fluorophore depth. A portable dual wavelength excitation fluorescence imaging system was built and tested in parallel with an NIR tumor-targeting fluorophore in tissue mimicking phantoms, chicken tissue, and in vivo mouse models of breast cancer. The system showed high accuracy in all experiments. The low cost and simplicity of this approach make it ideal for clinical use.
- 9 March 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (3) , 298-313
Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2
The heterogeneity and continuous genetic adaptation of tumours complicate their detection and treatment via the targeting of genetic mutations. However, hallmarks of cancer such as aberrant protein phosphorylation and calcium-mediated cell signalling provide broadly conserved molecular targets. Here, we show that, for a range of solid tumours, a cyclic octapeptide labelled with a near-infrared dye selectively binds to phosphorylated Annexin A2 (pANXA2), with high affinity at high levels of calcium. Because of cancer-cell-induced pANXA2 expression in tumour-associated stromal cells, the octapeptide preferentially binds to the invasive edges of tumours and then traffics within macrophages to the tumour’s necrotic core. As proof-of-concept applications, we used the octapeptide to detect tumour xenografts and metastatic lesions, and to perform fluorescence-guided surgical tumour resection, in mice. Our findings suggest that high levels of pANXA2 in association with elevated calcium are present in the microenvironment of most solid cancers. The octapeptide might be broadly useful for selective tumour imaging and for delivering drugs to the edges and to the core of solid tumours.
- 9 March 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (3) , 298-313
Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2
The heterogeneity and continuous genetic adaptation of tumours complicate their detection and treatment via the targeting of genetic mutations. However, hallmarks of cancer such as aberrant protein phosphorylation and calcium-mediated cell signalling provide broadly conserved molecular targets. Here, we show that, for a range of solid tumours, a cyclic octapeptide labelled with a near-infrared dye selectively binds to phosphorylated Annexin A2 (pANXA2), with high affinity at high levels of calcium. Because of cancer-cell-induced pANXA2 expression in tumour-associated stromal cells, the octapeptide preferentially binds to the invasive edges of tumours and then traffics within macrophages to the tumour’s necrotic core. As proof-of-concept applications, we used the octapeptide to detect tumour xenografts and metastatic lesions, and to perform fluorescence-guided surgical tumour resection, in mice. Our findings suggest that high levels of pANXA2 in association with elevated calcium are present in the microenvironment of most solid cancers. The octapeptide might be broadly useful for selective tumour imaging and for delivering drugs to the edges and to the core of solid tumours.
- Open Access
- 1 September 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (9) , 096010-6
Compact wearable dual-mode imaging system for real-time fluorescence image-guided surgery
A wearable all-plastic imaging system for real-time fluorescence image-guided surgery is presented. The compact size of the system is especially suitable for applications in the operating room. The system consists of a dual-mode imaging system, see-through goggle, autofocusing, and auto-contrast tuning modules. The paper will discuss the system design and demonstrate the system performance. Zhu, Huang, Mondal, Gao, Huang, Gruev, Achilefu, and Liang: Compact wearable dual-mode imaging system for real-time fluorescence image-guided surgery
- 1 September 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (9) , 096010-6
Open AccessCompact wearable dual-mode imaging system for real-time fluorescence image-guided surgery
A wearable all-plastic imaging system for real-time fluorescence image-guided surgery is presented. The compact size of the system is especially suitable for applications in the operating room. The system consists of a dual-mode imaging system, see-through goggle, autofocusing, and auto-contrast tuning modules. The paper will discuss the system design and demonstrate the system performance. Zhu, Huang, Mondal, Gao, Huang, Gruev, Achilefu, and Liang: Compact wearable dual-mode imaging system for real-time fluorescence image-guided surgery
- Open Access
- 16 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12117
Binocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping
The inability to identify microscopic tumors and assess surgical margins in real-time during oncologic surgery leads to incomplete tumor removal, increases the chances of tumor recurrence, and necessitates costly repeat surgery. To overcome these challenges, we have developed a wearable goggle augmented imaging and navigation system (GAINS) that can provide accurate intraoperative visualization of tumors and sentinel lymph nodes in real-time without disrupting normal surgical workflow. GAINS projects both near-infrared fluorescence from tumors and the natural color images of tissue onto a head-mounted display without latency. Aided by tumor-targeted contrast agents, the system detected tumors in subcutaneous and metastatic mouse models with high accuracy (sensitivity = 100%, specificity = 98% ± 5% standard deviation). Human pilot studies in breast cancer and melanoma patients using a near-infrared dye show that the GAINS detected sentinel lymph nodes with 100% sensitivity. Clinical use of the GAINS to guide tumor resection and sentinel lymph node mapping promises to improve surgical outcomes, reduce rates of repeat surgery, and improve the accuracy of cancer staging.
- 16 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12117
Open AccessBinocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping
The inability to identify microscopic tumors and assess surgical margins in real-time during oncologic surgery leads to incomplete tumor removal, increases the chances of tumor recurrence, and necessitates costly repeat surgery. To overcome these challenges, we have developed a wearable goggle augmented imaging and navigation system (GAINS) that can provide accurate intraoperative visualization of tumors and sentinel lymph nodes in real-time without disrupting normal surgical workflow. GAINS projects both near-infrared fluorescence from tumors and the natural color images of tissue onto a head-mounted display without latency. Aided by tumor-targeted contrast agents, the system detected tumors in subcutaneous and metastatic mouse models with high accuracy (sensitivity = 100%, specificity = 98% ± 5% standard deviation). Human pilot studies in breast cancer and melanoma patients using a near-infrared dye show that the GAINS detected sentinel lymph nodes with 100% sensitivity. Clinical use of the GAINS to guide tumor resection and sentinel lymph node mapping promises to improve surgical outcomes, reduce rates of repeat surgery, and improve the accuracy of cancer staging.
- 1 May 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 02714302,p. 1622-1625
A compact NIR fluorescence imaging system with goggle display for intraoperative guidance
Near infra-red (NIR) fluorescence imaging offers high sensitivity and specificity for cancer detection and tumor margin localization. In this paper, a compact and wearable NIR fluorescence imaging system (FIS) for image guided surgery is presented. The proposed FIS captures 27 frames per second of both NIR and visible spectrum data, allowing for minimum detection of 10nM of ICG concentration. The design tradeoffs of the complete system are carefully analyzed. The performance of the proposed FIS is evaluated under both sensitivity test and experimental mouse study. The imaging system is currently used in clinical trials for imaging sentinel lymph nodes in breast cancer and melanoma patients.
- 1 May 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 02714302,p. 1622-1625
A compact NIR fluorescence imaging system with goggle display for intraoperative guidance
Near infra-red (NIR) fluorescence imaging offers high sensitivity and specificity for cancer detection and tumor margin localization. In this paper, a compact and wearable NIR fluorescence imaging system (FIS) for image guided surgery is presented. The proposed FIS captures 27 frames per second of both NIR and visible spectrum data, allowing for minimum detection of 10nM of ICG concentration. The design tradeoffs of the complete system are carefully analyzed. The performance of the proposed FIS is evaluated under both sensitivity test and experimental mouse study. The imaging system is currently used in clinical trials for imaging sentinel lymph nodes in breast cancer and melanoma patients.
- 4 March 2015
- Published by SPIE-Intl Soc Optical Eng
- p. 931304-931304-8
Performance comparison of different compact NIR fluorescent imaging systems with goggle display for intraoperative image-guidance
- 4 March 2015
- Published by SPIE-Intl Soc Optical Eng
- p. 931304-931304-8
Performance comparison of different compact NIR fluorescent imaging systems with goggle display for intraoperative image-guidance
- Open Access
- 1 January 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (1) , 016018
Image overlay solution based on threshold detection for a compact near infrared fluorescence goggle system
Near infrared (NIR) fluorescence imaging has shown great potential for various clinical procedures, including intraoperative image guidance. However, existing NIR fluorescence imaging systems either have a large footprint or are handheld, which limits their usage in intraoperative applications. We present a compact NIR fluorescence imaging system (NFIS) with an image overlay solution based on threshold detection, which can be easily integrated with a goggle display system for intraoperative guidance. The proposed NFIS achieves compactness, light weight, hands-free operation, high-precision superimposition, and a real-time frame rate. In addition, the miniature and ultra-lightweight light-emitting diode tracking pod is easy to incorporate with NIR fluorescence imaging. Based on experimental evaluation, the proposed NFIS solution has a lower detection limit of 25 nM of indocyanine green at 27 fps and realizes a highly precise image overlay of NIR and visible images of mice in vivo. The overlay error is limited within a 2-mm scale at a 65-cm working distance, which is highly reliable for clinical study and surgical use.
- 1 January 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (1) , 016018
Open AccessImage overlay solution based on threshold detection for a compact near infrared fluorescence goggle system
Near infrared (NIR) fluorescence imaging has shown great potential for various clinical procedures, including intraoperative image guidance. However, existing NIR fluorescence imaging systems either have a large footprint or are handheld, which limits their usage in intraoperative applications. We present a compact NIR fluorescence imaging system (NFIS) with an image overlay solution based on threshold detection, which can be easily integrated with a goggle display system for intraoperative guidance. The proposed NFIS achieves compactness, light weight, hands-free operation, high-precision superimposition, and a real-time frame rate. In addition, the miniature and ultra-lightweight light-emitting diode tracking pod is easy to incorporate with NIR fluorescence imaging. Based on experimental evaluation, the proposed NFIS solution has a lower detection limit of 25 nM of indocyanine green at 27 fps and realizes a highly precise image overlay of NIR and visible images of mice in vivo. The overlay error is limited within a 2-mm scale at a 65-cm working distance, which is highly reliable for clinical study and surgical use.
- Open Access
- 1 July 2014
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 19 (7) , 076018
Engineering light-emitting diode surgical light for near-infrared fluorescence image-guided surgical systems
The near-infrared (NIR) fluorescence signal in the 700 to 900 nm from molecular probes used in fluorescence image-guided surgery (FIGS) is usually weak compared to the NIR component from white light-emitting diode surgical light, which is typically switched off during FIGS to enhance the molecular fluorescence contrast of the image. We propose a simple solution to this critical issue in FIGS by removing NIR light from surgical light with a low cost commercial 3M cool mirror film 330.
- 1 July 2014
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 19 (7) , 076018
Open AccessEngineering light-emitting diode surgical light for near-infrared fluorescence image-guided surgical systems
The near-infrared (NIR) fluorescence signal in the 700 to 900 nm from molecular probes used in fluorescence image-guided surgery (FIGS) is usually weak compared to the NIR component from white light-emitting diode surgical light, which is typically switched off during FIGS to enhance the molecular fluorescence contrast of the image. We propose a simple solution to this critical issue in FIGS by removing NIR light from surgical light with a low cost commercial 3M cool mirror film 330.
- 23 June 2014
- Published by Optica Publishing Group in Optics Letters
- Vol. 39 (13) , 3830-3832
Dual-mode optical imaging system for fluorescence image-guided surgery
In this Letter, we present a novel imaging concept that a single imaging system can image different spectral bands with different aperture sizes. It is achieved by using a filter with different transmitted spectral bands in different annular rings as the aperture stop. This concept will enable more efficient system configurations and practical clinical applications. We have demonstrated this concept with a dual-mode near-infrared fluorescence image guided surgical system.
- 23 June 2014
- Published by Optica Publishing Group in Optics Letters
- Vol. 39 (13) , 3830-3832
Dual-mode optical imaging system for fluorescence image-guided surgery
In this Letter, we present a novel imaging concept that a single imaging system can image different spectral bands with different aperture sizes. It is achieved by using a filter with different transmitted spectral bands in different annular rings as the aperture stop. This concept will enable more efficient system configurations and practical clinical applications. We have demonstrated this concept with a dual-mode near-infrared fluorescence image guided surgical system.
- 9 June 2014
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 25 (7) , 1272-1281
Antibody Quantum Dot Conjugates Developed via Copper-Free Click Chemistry for Rapid Analysis of Biological Samples Using a Microfluidic Microsphere Array System
Antibody-based proteomics is an enabling technology that has significant implications for cancer biomarker discovery, diagnostic screening, prognostic and pharmacodynamic evaluation of disease state, and targeted therapeutics. Quantum dot based fluoro-immunoconjugates possess promising features toward realization of this goal such as high photostability, brightness, and multispectral tunability. However, current strategies to generate such conjugates are riddled with complications such as improper orientation of antigen binding sites of the antibody, aggregation, and stability issues. We report a facile yet effective strategy to conjugate anti-epidermal growth factor receptor (EGFR) antibody to quantum dots using copper-free click reaction, and compared them to similar constructs prepared using traditional strategies such as succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) and biotin–streptavidin schemes. The Fc and Fab regions of the conjugates retain their binding potential, compared to those generated through the traditional schemes. We further applied the conjugates in testing a novel microsphere array device designed to carry out sensitive detection of cancer biomarkers through fluoroimmunoassays. Using purified EGFR, we determined the limit of detection of the microscopy centric system to be 12.5 ng/mL. The biological assay, in silico, was successfully tested and validated by using tumor cell lysates, as well as human serum from breast cancer patients, and the results were compared to normal serum. A pattern consistent with established clinical data was observed, which further validates the effectiveness of the developed conjugates and its successful implementation both in vitro as well as in silico fluoroimmunoassays. The results suggest the potential development of a high throughput in silico paradigm for predicting the class of patient cancer based on EGFR expression levels relative to normal reference levels in blood.
- 9 June 2014
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 25 (7) , 1272-1281
Antibody Quantum Dot Conjugates Developed via Copper-Free Click Chemistry for Rapid Analysis of Biological Samples Using a Microfluidic Microsphere Array System
Antibody-based proteomics is an enabling technology that has significant implications for cancer biomarker discovery, diagnostic screening, prognostic and pharmacodynamic evaluation of disease state, and targeted therapeutics. Quantum dot based fluoro-immunoconjugates possess promising features toward realization of this goal such as high photostability, brightness, and multispectral tunability. However, current strategies to generate such conjugates are riddled with complications such as improper orientation of antigen binding sites of the antibody, aggregation, and stability issues. We report a facile yet effective strategy to conjugate anti-epidermal growth factor receptor (EGFR) antibody to quantum dots using copper-free click reaction, and compared them to similar constructs prepared using traditional strategies such as succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) and biotin–streptavidin schemes. The Fc and Fab regions of the conjugates retain their binding potential, compared to those generated through the traditional schemes. We further applied the conjugates in testing a novel microsphere array device designed to carry out sensitive detection of cancer biomarkers through fluoroimmunoassays. Using purified EGFR, we determined the limit of detection of the microscopy centric system to be 12.5 ng/mL. The biological assay, in silico, was successfully tested and validated by using tumor cell lysates, as well as human serum from breast cancer patients, and the results were compared to normal serum. A pattern consistent with established clinical data was observed, which further validates the effectiveness of the developed conjugates and its successful implementation both in vitro as well as in silico fluoroimmunoassays. The results suggest the potential development of a high throughput in silico paradigm for predicting the class of patient cancer based on EGFR expression levels relative to normal reference levels in blood.